Has Ruth Bibeau, APRN received payments from drug or device companies?

Yes. Drug and device makers reported $885 in general payments to Ruth Bibeau, APRN across 39 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ruth Bibeau, APRN did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ruth Bibeau, APRN come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ruth Bibeau, APRN

Psychiatric/Mental Health · Tupelo, MSNPI 1851983704

Payments from drug & device makers

$885in general payments, 2019–2025

Across 39 payments — averaging $22.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$232
Axsome Therapeutics, Inc.$131
Otsuka America Pharmaceutical, Inc.$100
Johnson & Johnson$97
AbbVie$79
Takeda Pharmaceuticals U.S.A., Inc.$52
plus $194 from 7 others

What the payments were for

Food & beverage$885100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	5	$232
Axsome Therapeutics, Inc.	4	$131
Otsuka America Pharmaceutical, Inc.	6	$100
Johnson & Johnson	5	$97
AbbVie	6	$79
Takeda Pharmaceuticals U.S.A., Inc.	3	$52
Bausch Health US, LLC	2	$47
Supernus Pharmaceuticals, Inc.	2	$34
Avanir Pharmaceuticals, Inc.	2	$32
E.r. Squibb & Sons, L.L.C.	1	$30
Teva Pharmaceuticals USA, Inc.	1	$18
Vanda Pharmaceuticals Inc.	1	$18
Collegium Pharmaceutical, Inc.	1	$15

How this compares

$885 in reported general payments places this provider in the 55th percentile of 486 psychiatric/mental health providers in Mississippi.

See all psychiatric/mental health providers in Mississippi →

Medicare billing

Part B allowed, 2024

$7,517

Medicare patients

Services billed

109

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Clonazepam	12	$40

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Tupelo

Amanda ThomasTupelo$41K
Ashley KarelVicksburg$129K
Amanda HamCorinth$64K
Alanna WrightJackson$58K
Amelia KelleyMeridian$38K
Belinda EdwardsJackson$29K
Lawanda GlassCleveland$22K
Rebecca HartzogHattiesburg$17K
Leigh CalcoteHattiesburg$15K
Rose CliffordGautier$14K

See the full list for Mississippi →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →